Evidence map›Paper›PMID 38095464›Full record

ArticleMicrobiology spectrum2024

Structure-based virtual screening and

Akshay Rohilla, Alok Kumar Singh, Benjamin Koleske, Geetha Srikrishna, William R Bishai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Prophage: agent provocateur?Archives of microbiology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Akshay Rohilla *Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.
Alok Kumar Singh *Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.
Benjamin KoleskeDepartment of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.
Geetha SrikrishnaDepartment of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.
William R BishaiDepartment of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.ORCID 0000-0002-8734-4118
Johns Hopkins University · US

Funding

Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Mycobacterium tuberculosis Survival Regulatory GenesR01AI037856 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 1997 to 2020
$7.2M
A STINGing vaccine for TBR01AI155346 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES, MEHRA, SMRITI · 2020 to 2024
$4.9M
NIAID NIH HHS R01 AI037856NIAID NIH HHS R01 AI155346NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

importanceIn this paper, we describe novel inhibitors of cyclic dinucleotide phosphodiesterase enzymes from

Indexed as

Mycobacterium tuberculosisNeoplasmsAnimalsHumansMacrophagesMammalsNucleotidyltransferasesPhosphoric Diester HydrolasesNucleotidyltransferasesPhosphoric Diester Hydrolasescyclic dinucleotide phosphodiesterasehost-directed therapyimmune evasionMycobacterium tuberculosis

Identifiers

PMID38095464
PMCPMC10783014
OpenAlexW4389732667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.